ChiCTR2600126232 版本V1.0 版本创建时间2026/06/05 10:56:57 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600126232 

最近更新日期:

Date of Last Refreshed on:

2026-06-05 10:56:30 

注册时间:

Date of Registration:

2026-06-05 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

中枢-外周闭环式磁刺激治疗脊髓损伤后神经源性膀胱疗效的临床研究

Public title:

Clinical study of central-peripheral closed-loop magnetic stimulation in the treatment of neurogenic bladder after spinal cord injury

注册题目简写:

English Acronym:

研究课题的正式科学名称:

中枢-外周闭环式磁刺激治疗脊髓损伤后神经源性膀胱疗效的临床研究

Scientific title:

Clinical study of central-peripheral closed-loop magnetic stimulation in the treatment of neurogenic bladder after spinal cord injury

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

李超 

研究负责人:

李超 

Applicant:

Li Chao 

Study leader:

Li Chao 

申请注册联系人电话:

Applicant telephone:

+86 189 1909 0630

研究负责人电话:

Study leader's
telephone:

+86 189 1909 0630

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1335779645@qq.com

研究负责人电子邮件:

Study leader's E-mail:

1335779645@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

甘肃省兰州市七里河区瓜州路418号(甘肃省中医院)

研究负责人通讯地址:

甘肃省兰州市七里河区瓜州路418号(甘肃省中医院)

Applicant address:

No.418, Guazhou Road, Qilihe District, Lanzhou City, Gansu Province ( Gansu Provincial Hospital of Traditional Chinese Medicine )

Study leader's address:

No.418, Guazhou Road, Qilihe District, Lanzhou City, Gansu Province ( Gansu Provincial Hospital of Traditional Chinese Medicine )

申请注册联系人邮政编码:

Applicant postcode:

730050

研究负责人邮政编码:

Study leader's postcode:

730050

申请人所在单位:

甘肃省中医院

Applicant's institution:

Gansu Provincial Hospital of Traditional Chinese Medicine

研究负责人所在单位:

甘肃省中医院

Affiliation of the Leader:

Gansu Provincial Hospital of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2026-058-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

甘肃省中医院伦理委员会

Name of the ethic committee:

Ethics Committee of Gansu Provincial Hospital of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2026-03-25 00:00:00

伦理委员会联系人:

李玉梅

Contact Name of the ethic committee:

Li Yumei

伦理委员会联系地址:

甘肃省兰州市七里河区甘肃省中医院

Contact Address of the ethic committee:

Gansu Provincial Hospital of Traditional Chinese Medicine, Qilihe District, Lanzhou City, Gansu Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 1391152952

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

甘肃省中医院

Primary sponsor:

Gansu Provincial Hospital of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

甘肃省兰州市七里河区瓜州路418号

Primary sponsor's address:

No.418, Guazhou Road, Qilihe District, Lanzhou City, Gansu Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

甘肃省

市(区县):

兰州市

Country:

China

Province:

Gansu

City:

Lanzhou

单位(医院):

甘肃省中医院

具体地址:

甘肃省兰州市七里河区瓜州路418号

Institution
hospital:

Gansu Provincial Hospital of Traditional Chinese Medicine

Address:

No.418, Guazhou Road, Qilihe District, Lanzhou City, Gansu Province

经费或物资来源:

自筹经费

Source(s) of funding:

Self-financing

研究疾病:

脊髓损伤;神经源性膀胱  

Target disease:

Spinal cord injury ; neurogenic bladder

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

探讨中枢-外周闭环式磁刺激对脊髓损伤后神经源性膀胱的临床疗效与安全性。  

Objectives of Study:

To investigate the clinical efficacy and safety of central-peripheral closed-loop magnetic stimulation on neurogenic bladder after spinal cord injury.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.符合《脊髓损伤神经学分类国际标准(2019版)》诊断,经CT/MRI证实,脊髓休克期已过; 2. 尿动力学确诊为逼尿肌无反射/低张力型神经源性膀胱,残余尿量>100 mL; 3.年龄18~65岁,ASIA分级B~D级; 4. 生命体征平稳,意识清楚,可配合治疗与评估; 5.签署知情同意书,本研究经医院伦理委员会批准。

Inclusion criteria

1.According to the International Standard for Neurological Classification of Spinal Cord Injury ( 2019 Edition ), the diagnosis was confirmed by CT / MRI, and the shock stage of spinal cord was over. 2.urodynamic diagnosis of detrusor areflexia / low tension neurogenic bladder, residual urine volume > 100 mL ; 3.18-65 years old, ASIA grade B-D ; 4.stable vital signs, clear consciousness, can cooperate with treatment and evaluation ; 5.signed the informed consent form, this study was approved by the hospital ethics committee.

排除标准:

1. 颅脑损伤、癫痫、颅内金属植入物、心脏起搏器; 2. 严重泌尿系感染、结石、尿道梗阻、肾功能不全; 3. 妊娠、认知障碍、精神疾病; 4. 近1个月接受过磁刺激或其他神经调控治疗。

Exclusion criteria:

1.craniocerebral injury, epilepsy, intracranial metal implants, cardiac pacemaker ; 2. severe urinary tract infection, calculi, urethral obstruction, renal insufficiency ; 3. pregnancy, cognitive impairment, mental illness ; 4.Patients received magnetic stimulation or other neuromodulation therapy in the past 1 month.

研究实施时间:

Study execute time:

From 2026-04-01 00:00:00 To 2026-12-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-07-01 00:00:00 To 2026-09-01 00:00:00

干预措施:

Interventions:

组别:

试验组

样本量:

30

Group:

Test team

Sample size:

干预措施:

试验组:在对照组治疗基础上,加用重复经颅磁刺激(rTMS)联合骶神经根外周磁刺激,形成中枢-外周闭环干预。

干预措施代码:

Intervention:

Experimental group : on the basis of the treatment of the control group, repetitive transcranial magnetic stimulation ( rTMS ) combined with peripheral magnetic stimulation of sacral nerve root was added to form a central-peripheral closed-loop intervention.

Intervention code:

组别:

对照组

样本量:

30

Group:

Control group

Sample size:

干预措施:

对照组:常规膀胱康复治疗 采用间歇性清洁导尿(CIC)联合基础膀胱训练,参照神经源性膀胱护理指南执行

干预措施代码:

Intervention:

Control group : conventional bladder rehabilitation treatment Intermittent clean catheterization ( CIC ) combined with basic bladder training was performed with reference to neurogenic bladder nursing guidelines

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

甘肃省 

市(区县):

兰州市 

Country:

China

Province:

Gansu

City:

Lanzhou

单位(医院):

甘肃省中医院 

单位级别:

三甲 

Institution
hospital:

Gansu Provincial Hospital of Traditional Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

膀胱残余尿量

指标类型:

主要指标

Outcome:

Bladder residual urine volume

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

最大膀胱容量

指标类型:

主要指标

Outcome:

Maximum bladder capacity

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

日均排尿次数

指标类型:

主要指标

Outcome:

Average daily urination times

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

24 小时漏尿次数

指标类型:

次要指标

Outcome:

24-hour urine leakage times

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

国际下尿路症状评分

指标类型:

次要指标

Outcome:

International Lower Urinary Tract Symptom Score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生活质量评分

指标类型:

次要指标

Outcome:

Quality of life score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

不良反应发生率

指标类型:

次要指标

Outcome:

Incidence of adverse reactions

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 65 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由未参与患者招募、评估与治疗的第三方统计人员,依据样本量使用SPSS22.0软件生成随机数字序列,将60例研究对象按1:1比例分为试验组与对照组,每组30例,从1开始到60编号,从随机数字表中任一行任一列开始,依次读取两位数作为一份随机数录于编号下,然后将全部随机数从小到大编序号,将每个随机数对应序号登记在表,规定序号1-30为试验组,序号31-60为对照组。

Randomization Procedure (please state who generates the random number sequence and by what method):

The third-party statisticians who did not participate in the recruitment, evaluation and treatment of patients used SPSS22.0 software to generate a random number sequence according to the sample size. The 60 subjects were divided into experimental group and control group according to the ratio of 1 : 1, with 30 cases in each group. From 1 to 60 numbers, starting from any column of any row in the random number table, two digits were read in turn as a random number, and then all random numbers were serialized from small to large. The corresponding serial number of each random number was registered in the table. The serial number 1-30 was the experimental group, and the serial number 31-60 was the control group.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

本研究实施评估者单盲,分组信息对结局评估者保密,所有疗效指标由不知情的专职人员统一评定,以减少测量偏倚。

Blinding:

In this study, the evaluator was single-blind, and the grouping information was confidential to the outcome evaluator. All efficacy indicators were evaluated by uninformed professionals to reduce measurement bias.

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Electronic Data Capture, EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2026-06-05 10:56:30